By tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead.
DrugPatentWatch Database Preview
Drugs in Development Information for IW-1973
Email this page to a colleague
What is the drug development status for IW-1973?
IW-1973 is an investigational drug.
There have been 7 clinical trials for IW-1973.
The most recent clinical trial was a Phase 1 trial, which was initiated on October 1st 2017.
The most common disease conditions in clinical trials are Diabetes Mellitus, Type 2, Diabetes Mellitus, and Hypertension. The leading clinical trial sponsors are Ironwood Pharmaceuticals, Inc. and [disabled in preview].
There are four US patents protecting this investigational drug and forty international patents.
Summary for IW-1973
| US Patents | 4 |
| International Patents | 40 |
| US Patent Applications | 18 |
| WIPO Patent Applications | 12 |
| Japanese Patent Applications | 4 |
| Clinical Trial Progress | Phase 1 (2017-10-01) |
| Vendors | 9 |
Recent Clinical Trials for IW-1973
| Title | Sponsor | Phase |
|---|---|---|
| A Trial to Study the Absorption, Metabolism, and Excretion of [14C]-Praliciguat in Healthy Male Volunteers | Ironwood Pharmaceuticals, Inc. | Phase 1 |
| A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Inhibitor Praliciguat (IW-1973) in Healthy Volunteers | Ironwood Pharmaceuticals, Inc. | Phase 1 |
| A Study of the Effect of IW-1973 on the Exercise Capacity of Patients With Heart Failure With Preserved Ejection Fraction (HFpEF) | Ironwood Pharmaceuticals, Inc. | Phase 2 |
Clinical Trial Summary for IW-1973
Top disease conditions for IW-1973
Top clinical trial sponsors for IW-1973
US Patents for IW-1973
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| IW-1973 | Get Started Free | sGC stimulators | Ironwood Pharmaceuticals, Inc. (Cambridge, MA) | Get Started Free |
| IW-1973 | Get Started Free | sGC stimulators | Cyclerion Therapeutics, Inc. (Cambridge, MA) | Get Started Free |
| IW-1973 | Get Started Free | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | Get Started Free |
| IW-1973 | Get Started Free | sGC stimulators | IRONWOOD PHARMACEUTICALS, INC. (Cambridge, MA) | Get Started Free |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for IW-1973
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| IW-1973 | Australia | AU2014227862 | 2033-03-15 | Get Started Free |
| IW-1973 | Australia | AU2019203606 | 2033-03-15 | Get Started Free |
| IW-1973 | Brazil | BR112015023349 | 2033-03-15 | Get Started Free |
| IW-1973 | Canada | CA2907111 | 2033-03-15 | Get Started Free |
| IW-1973 | China | CN105408328 | 2033-03-15 | Get Started Free |
| IW-1973 | China | CN108912111 | 2033-03-15 | Get Started Free |
| IW-1973 | China | CN109369635 | 2033-03-15 | Get Started Free |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
